Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Interventions to control nosocomial transmission of SARS-CoV-2: a modelling study

View ORCID ProfileThi Mui Pham, View ORCID ProfileHannan Tahir, View ORCID ProfileJanneke H.H.M. van de Wijgert, View ORCID ProfileBastiaan Van der Roest, Pauline Ellerbroek, View ORCID ProfileMarc J.M. Bonten, View ORCID ProfileMartin C.J. Bootsma, View ORCID ProfileMirjam E. Kretzschmar
doi: https://doi.org/10.1101/2021.02.26.21252327
Thi Mui Pham
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thi Mui Pham
  • For correspondence: t.m.pham-2@umcutrecht.nl
Hannan Tahir
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hannan Tahir
  • For correspondence: t.m.pham-2@umcutrecht.nl
Janneke H.H.M. van de Wijgert
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
2Institute of Infection, Veterinary, and Ecological Sciences, University of Liverpool, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Janneke H.H.M. van de Wijgert
Bastiaan Van der Roest
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bastiaan Van der Roest
Pauline Ellerbroek
3Department of Internal Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc J.M. Bonten
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
5Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc J.M. Bonten
Martin C.J. Bootsma
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
4Mathematical Institute, Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin C.J. Bootsma
Mirjam E. Kretzschmar
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mirjam E. Kretzschmar
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Emergence of more transmissible SARS-CoV-2 variants requires more efficient control measures to limit nosocomial transmission and maintain healthcare capacities during pandemic waves. Yet, the relative importance of different strategies is unknown.

Methods We developed an agent-based model and compared the impact of personal protective equipment (PPE), screening of healthcare workers (HCWs), contact tracing of symptomatic HCWs, and restricting HCWs from working in multiple units (HCW cohorting) on nosocomial SARS-CoV-2 transmission. The model was fit on hospital data from the first wave in the Netherlands (February until August 2020) and assumed that HCWs used 90% effective PPE in COVID-19 wards and self-isolated at home for seven days immediately upon symptom onset. Intervention effects on the effective reproduction number (RE), HCW absenteeism and the proportion of infected individuals among tested individuals (positivity rate) were estimated for a more transmissible variant.

Results Introduction of a variant with 56% higher transmissibility increased – all other variables kept constant – RE from 0.4 to 0.65 (+63%) and nosocomial transmissions by 303%, mainly because of more transmissions caused by pre-symptomatic patients and HCWs. Compared to baseline, PPE use in all hospital wards (assuming 90% effectiveness) reduced RE by 85% and absenteeism by 57%. Screening HCWs every three days with perfect test sensitivity reduced RE by 67%, yielding a maximum test positivity rate of 5%. Screening HCWs every three or seven days assuming time-varying test sensitivities reduced RE by 9% and 3%, respectively. Contact tracing reduced RE by at least 32% and achieved higher test positivity rates than screening interventions. HCW cohorting reduced RE by 5%. Sensitivity analyses for 50% and 70% effectiveness of PPE use did not change interpretation.

Conclusions In response to the emergence of more transmissible SARS-CoV-2 variants, PPE use in all hospital wards might still be most effective in preventing nosocomial transmission. Regular screening and contact tracing of HCWs are also effective interventions, but critically depend on the sensitivity of the diagnostic test used.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

MK was supported by ZonMw grant number 10430022010001. MK and HT were supported by ZonMw grant number 547001005 within the 3rd JPI ARM framework (Joint Programming Initiative on Antimicrobial Resistance) cofound grant no 681055 for the consortium EMerGE-Net). MB was supported by RECOVER (Rapid European COVID-19 Emergency research Response), which has received funding from the EU Horizon 2020 research and innovation programme (grant agreement number 101003589).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This is a modeling study which did not require IRB and/or ethics committee approvals. All data is publicly available.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data and code used in the manuscript are available from: https://github.com/htahir2/covid_intra-hospital_model

https://data.rivm.nl/covid-19/COVID-19_prevalentie.json

https://opendata.cbs.nl/statline/#/CBS/nl/dataset/71857ned/table?ts=1517582466533

http://doi.org/10.5281/zenodo.3711575

http://doi.org/10.5281/zenodo.3711575

https://github.com/htahir2/covid_intra-hospital_model/blob/main/data/covid_patient_admissions_los_UMCU.csv

  • Abbreviations

    COVID-19
    Coronavirus disease 2019
    HCW
    Healthcare worker
    ICU
    Intensive-care unit
    LTCF
    Long-term care facilities
    PPE
    Personal protective equipment
    RT-PCR
    Reverse transcriptase polymerase chain reaction
    RE
    Effective reproduction number
    RIVM
    Rijksinstituut voor Volksgezondheid en Milieu (Dutch National Institute for Public Health and the Environment)
    SARS-CoV-2
    Severe acute respiratory syndrome coronavirus 2
    SEIR
    Susceptible-Exposed-Infectious-Recovered
    UMCU
    University Medical Center Utrecht
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted March 23, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Interventions to control nosocomial transmission of SARS-CoV-2: a modelling study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Interventions to control nosocomial transmission of SARS-CoV-2: a modelling study
    Thi Mui Pham, Hannan Tahir, Janneke H.H.M. van de Wijgert, Bastiaan Van der Roest, Pauline Ellerbroek, Marc J.M. Bonten, Martin C.J. Bootsma, Mirjam E. Kretzschmar
    medRxiv 2021.02.26.21252327; doi: https://doi.org/10.1101/2021.02.26.21252327
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Interventions to control nosocomial transmission of SARS-CoV-2: a modelling study
    Thi Mui Pham, Hannan Tahir, Janneke H.H.M. van de Wijgert, Bastiaan Van der Roest, Pauline Ellerbroek, Marc J.M. Bonten, Martin C.J. Bootsma, Mirjam E. Kretzschmar
    medRxiv 2021.02.26.21252327; doi: https://doi.org/10.1101/2021.02.26.21252327

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (227)
    • Allergy and Immunology (500)
    • Anesthesia (110)
    • Cardiovascular Medicine (1226)
    • Dentistry and Oral Medicine (205)
    • Dermatology (147)
    • Emergency Medicine (282)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (528)
    • Epidemiology (9998)
    • Forensic Medicine (5)
    • Gastroenterology (497)
    • Genetic and Genomic Medicine (2441)
    • Geriatric Medicine (236)
    • Health Economics (479)
    • Health Informatics (1634)
    • Health Policy (750)
    • Health Systems and Quality Improvement (633)
    • Hematology (247)
    • HIV/AIDS (530)
    • Infectious Diseases (except HIV/AIDS) (11854)
    • Intensive Care and Critical Care Medicine (625)
    • Medical Education (251)
    • Medical Ethics (74)
    • Nephrology (267)
    • Neurology (2271)
    • Nursing (139)
    • Nutrition (349)
    • Obstetrics and Gynecology (451)
    • Occupational and Environmental Health (532)
    • Oncology (1244)
    • Ophthalmology (375)
    • Orthopedics (133)
    • Otolaryngology (226)
    • Pain Medicine (154)
    • Palliative Medicine (50)
    • Pathology (324)
    • Pediatrics (728)
    • Pharmacology and Therapeutics (311)
    • Primary Care Research (281)
    • Psychiatry and Clinical Psychology (2279)
    • Public and Global Health (4822)
    • Radiology and Imaging (833)
    • Rehabilitation Medicine and Physical Therapy (488)
    • Respiratory Medicine (650)
    • Rheumatology (283)
    • Sexual and Reproductive Health (237)
    • Sports Medicine (224)
    • Surgery (266)
    • Toxicology (44)
    • Transplantation (124)
    • Urology (99)